Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Sales: 2014-2025

Historic Return on Sales for Fennec Pharmaceuticals (FENC) over the last 5 years, with Sep 2025 value amounting to -0.17%.

  • Fennec Pharmaceuticals' Return on Sales fell 15.00% to -0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.17%, marking a year-over-year decrease of 15.00%. This contributed to the annual value of -0.01% for FY2024, which is 75.00% up from last year.
  • Fennec Pharmaceuticals' Return on Sales amounted to -0.17% in Q3 2025, which was up 52.03% from -0.35% recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Return on Sales registered a high of 132.05% during Q1 2022, and its lowest value of -124.06% during Q3 2021.
  • Moreover, its 3-year median value for Return on Sales was -0.35% (2025), whereas its average is -5.57%.
  • As far as peak fluctuations go, Fennec Pharmaceuticals' Return on Sales skyrocketed by 22,902bps in 2022, and later crashed by 18,204bps in 2023.
  • Fennec Pharmaceuticals' Return on Sales (Quarterly) stood at -124.06% in 2021, then surged by 19,624bps to 23.50% in 2022, then slumped by 2,424bps to -0.74% in 2023, then skyrocketed by 74bps to 0.00% in 2024, then declined by 15bps to -0.17% in 2025.
  • Its last three reported values are -0.17% in Q3 2025, -0.35% for Q2 2025, and -0.45% during Q1 2025.